Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $73,255 | 15 | 63.4% |
| Travel and Lodging | $36,109 | 16 | 31.2% |
| Food and Beverage | $6,175 | 98 | 5.3% |
| Education | $93.83 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Glaukos Corporation | $113,295 | 65 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $585.22 | 14 | $0 (2020) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $370.95 | 6 | $0 (2019) |
| EYEVANCE PHARMACEUTICALS LLC | $329.44 | 4 | $0 (2022) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $205.12 | 5 | $0 (2024) |
| Allergan, Inc. | $172.71 | 4 | $0 (2021) |
| Harrow Eye, LLC | $122.05 | 6 | $0 (2024) |
| Oyster Point Pharma, Inc. | $114.34 | 6 | $0 (2024) |
| Shire North American Group Inc | $78.34 | 5 | $0 (2019) |
| Alcon Vision LLC | $70.80 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,812 | 15 | Glaukos Corporation ($5,491) |
| 2023 | $41,683 | 25 | Glaukos Corporation ($41,621) |
| 2022 | $66,187 | 42 | GLAUKOS CORPORATION ($65,901) |
| 2021 | $365.67 | 6 | Glaukos Corporation ($187.23) |
| 2020 | $47.45 | 2 | Sun Pharmaceutical Industries Inc. ($24.13) |
| 2019 | $1,037 | 25 | Aerie Pharmaceuticals, Inc. ($360.28) |
| 2018 | $403.29 | 11 | Aerie Pharmaceuticals, Inc. ($201.62) |
| 2017 | $96.85 | 5 | Shire North American Group Inc ($28.00) |
All Payment Transactions
131 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: OPTOMETRY | ||||||
| 11/22/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/20/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $121.85 | General |
| Category: Ophthalmology | ||||||
| 10/01/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: OPTOMETRY | ||||||
| 09/12/2024 | Oyster Point Pharma, Inc. | RYZUMVI (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Pharmacologically-induced mydriasis | ||||||
| 07/15/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: OPTOMETRY | ||||||
| 06/12/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Ophthalmology | ||||||
| 05/23/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Dry eyes | ||||||
| 04/30/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $28.23 | General |
| Category: OPTOMETRY | ||||||
| 04/17/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Travel and Lodging | Cash or cash equivalent | $2,909.25 | General |
| Category: Corneal Health | ||||||
| 04/17/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Travel and Lodging | Cash or cash equivalent | $2,168.05 | General |
| Category: Corneal Health | ||||||
| 04/10/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: OPTOMETRY | ||||||
| 03/15/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Food and Beverage | Cash or cash equivalent | $274.89 | General |
| Category: Corneal Health | ||||||
| 02/28/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Food and Beverage | Cash or cash equivalent | $139.26 | General |
| Category: Corneal Health | ||||||
| 01/30/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: OPTOMETRY | ||||||
| 11/20/2023 | Glaukos Corporation | iStent infinite Trabecular Micro-Bypass System Model iS3 (Device) | Food and Beverage | Cash or cash equivalent | $35.13 | General |
| Category: Glaucoma | ||||||
| 10/11/2023 | Glaukos Corporation | KXL system (not refurbished) (Device) | Consulting Fee | Cash or cash equivalent | $2,725.00 | General |
| Category: Corneal Health | ||||||
| 10/11/2023 | Glaukos Corporation | KXL system (not refurbished) (Device) | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| Category: Corneal Health | ||||||
| 10/11/2023 | Glaukos Corporation | KXL system (not refurbished) (Device) | Travel and Lodging | Cash or cash equivalent | $1,688.11 | General |
| Category: Corneal Health | ||||||
| 10/11/2023 | Glaukos Corporation | KXL system (not refurbished) (Device) | Travel and Lodging | Cash or cash equivalent | $1,029.85 | General |
| Category: Corneal Health | ||||||
| 09/27/2023 | Glaukos Corporation | KXL system (not refurbished) (Device) | Consulting Fee | Cash or cash equivalent | $875.00 | General |
| Category: Corneal Health | ||||||
| 09/27/2023 | Glaukos Corporation | KXL system (not refurbished) (Device) | Consulting Fee | Cash or cash equivalent | $175.00 | General |
| Category: Corneal Health | ||||||
| 08/16/2023 | Glaukos Corporation | — | Food and Beverage | Cash or cash equivalent | $136.67 | General |
| 08/16/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Education | In-kind items and services | $17.84 | General |
| Category: Ophthalmology | ||||||
| 08/11/2023 | Glaukos Corporation | — | Food and Beverage | Cash or cash equivalent | $175.81 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,020 | 1,390 | $296,080 | $108,028 |
| 2022 | 9 | 1,011 | 1,337 | $267,050 | $103,059 |
| 2021 | 5 | 261 | 298 | $50,865 | $24,860 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 240 | 518 | $108,100 | $42,362 | 39.2% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 291 | 342 | $95,350 | $38,418 | 40.3% |
| 92250 | Photography of the retina | Office | 2023 | 281 | 306 | $42,840 | $10,420 | 24.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 74 | 74 | $23,950 | $9,745 | 40.7% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 32 | 37 | $6,105 | $2,161 | 35.4% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 28 | 28 | $5,850 | $2,125 | 36.3% |
| 92134 | Imaging of retina | Office | 2023 | 30 | 34 | $3,400 | $1,233 | 36.3% |
| 92133 | Imaging of optic nerve | Office | 2023 | 20 | 21 | $2,625 | $705.57 | 26.9% |
| 92071 | Fitting of contact lens for treatment of eye surface disease | Office | 2023 | 13 | 19 | $6,650 | $607.35 | 9.1% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 11 | 11 | $1,210 | $251.60 | 20.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 251 | 503 | $98,860 | $41,139 | 41.6% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 289 | 325 | $86,780 | $36,012 | 41.5% |
| 92250 | Photography of the retina | Office | 2022 | 264 | 291 | $39,840 | $9,924 | 24.9% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 71 | 71 | $22,065 | $9,584 | 43.4% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 32 | 34 | $5,610 | $2,039 | 36.3% |
| 92134 | Imaging of retina | Office | 2022 | 38 | 44 | $4,400 | $1,633 | 37.1% |
| 92002 | New patient problem focused exam of visual system | Office | 2022 | 18 | 18 | $3,520 | $1,366 | 38.8% |
| 92133 | Imaging of optic nerve | Office | 2022 | 32 | 35 | $4,375 | $1,189 | 27.2% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 16 | 16 | $1,600 | $173.49 | 10.8% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 68 | 69 | $14,435 | $7,692 | 53.3% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 52 | 88 | $14,550 | $7,453 | 51.2% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 45 | 45 | $11,370 | $6,272 | 55.2% |
| 92250 | Photography of the retina | Office | 2021 | 82 | 82 | $8,760 | $2,949 | 33.7% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 14 | 14 | $1,750 | $494.48 | 28.3% |
About Eric Conley, OD, MJ
Eric Conley, OD, MJ is a Optometrist healthcare provider based in Wantagh, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1639202211.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Eric Conley, OD, MJ has received a total of $115,633 in payments from pharmaceutical and medical device companies, with $5,812 received in 2024. These payments were reported across 131 transactions from 19 companies. The most common payment nature is "Consulting Fee" ($73,255).
As a Medicare-enrolled provider, Conley has provided services to 2,292 Medicare beneficiaries, totaling 3,025 services with total Medicare billing of $235,947. Data is available for 3 years (2021–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Other Specialties Optometrist
- Location Wantagh, NY
- Active Since 03/13/2007
- Last Updated 09/03/2025
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1639202211
Products in Payments
- ILINK (Device) $33,433
- KXL system (not refurbished) (Device) $31,926
- CE-marked KXLA system (Device) $5,491
- ISTENT INJECT W (Device) $3,124
- KXL SYSTEM (Device) $1,205
- Rhopressa (Drug) $442.56
- LOTEMAX SM (Drug) $209.77
- Cequa (Drug) $158.54
- iStent inject W (Device) $150.40
- LUMIGAN (Drug) $132.89
- VEVYE (Drug) $122.05
- Zerviate (Drug) $121.80
- ZERVIATE (Drug) $117.15
- ENVISTA (Device) $116.46
- TYRVAYA (Drug) $97.17
- iStent inject Trabecular Micro-Bypass Stent System (Device) $93.87
- XIIDRA (Drug) $78.34
- TRAVATAN Z (Drug) $43.04
- Hydrus (Device) $42.85
- AcrySof (Device) $39.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.